Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Christopher Seder and Michael Liptay.
Christopher Seder
Connection Strength
1.973
Michael Liptay
  1. Conditional survival analysis of patients with resected non-small cell lung cancer. JTCVS Open. 2023 Dec; 16:948-959.
    View in: PubMed
    Score: 0.201
  2. Low-Dose Computed Tomography Scan Features Are Associated With Annual Risk of Hospitalization. Ann Thorac Surg Short Rep. 2023 Dec; 1(4):558-561.
    View in: PubMed
    Score: 0.199
  3. The association between thoracic sarcopenia and survival is gender specific in early-stage lung cancer. J Thorac Dis. 2022 Nov; 14(11):4256-4265.
    View in: PubMed
    Score: 0.189
  4. Predicting Non-home Discharge After Lung Surgery: Analysis of the General Thoracic Surgery Database. Ann Thorac Surg. 2023 03; 115(3):687-692.
    View in: PubMed
    Score: 0.186
  5. Sarcopenia after induction therapy is associated with reduced survival in patients undergoing esophagectomy for locally-advanced esophageal cancer. J Thorac Dis. 2021 Feb; 13(2):861-869.
    View in: PubMed
    Score: 0.168
  6. Understanding barriers to lung cancer screening in primary care. J Thorac Dis. 2020 May; 12(5):2536-2544.
    View in: PubMed
    Score: 0.159
  7. A Prolonged Air Leak Score for Lung Cancer Resection: An Analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database. Ann Thorac Surg. 2019 11; 108(5):1478-1483.
    View in: PubMed
    Score: 0.151
  8. Improved False-Positive Rates and the Overestimation of Unintended Harm from Lung Cancer Screening. Lung. 2019 06; 197(3):327-332.
    View in: PubMed
    Score: 0.148
  9. The History of the Department of Cardiovascular and Thoracic Surgery at Rush. Semin Thorac Cardiovasc Surg. 2016 Autumn; 28(3):687-699.
    View in: PubMed
    Score: 0.125
  10. Early pneumonectomy for pulmonary mucormycosis. Ann Thorac Surg. 2015 Mar; 99(3):e67-8.
    View in: PubMed
    Score: 0.111
  11. Association Between Rare Germline Variants in Cancer Susceptibility Genes and Lung Cancer Risk. Ann Thorac Surg. 2026 Jul 31.
    View in: PubMed
    Score: 0.061
  12. Microfluidic lung cancer models: Bridging clinical treatment strategies and tumor microenvironment recapitulation. APL Bioeng. 2025 Dec; 9(4):041505.
    View in: PubMed
    Score: 0.059
  13. Exploratory Algorithms to Aid in Risk of Malignancy Prediction for Indeterminate Pulmonary Nodules. Cancers (Basel). 2025 Apr 05; 17(7).
    View in: PubMed
    Score: 0.056
  14. The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer. Oncotarget. 2022; 13:393-407.
    View in: PubMed
    Score: 0.045
  15. Circulating histocompatibility antigen (HLA) gene products may help differentiate benign from malignant indeterminate pulmonary lesions. Hum Immunol. 2018 Jul; 79(7):558-563.
    View in: PubMed
    Score: 0.034
  16. Relationship Between Radiation Therapy Dose and Outcome in Patients Treated With Neoadjuvant Chemoradiation Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer: A Population-Based, Comparative Effectiveness Analysis. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):307-16.
    View in: PubMed
    Score: 0.028
  17. Circulating angiogenesis biomarkers are associated with disease progression in lung adenocarcinoma. Ann Thorac Surg. 2014 Dec; 98(6):1968-75; discussion 1975.
    View in: PubMed
    Score: 0.027
  18. Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2015 Mar; 149(3):727-34.e1-3; discussion 734.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.